The failure of Pfizer Inc.’s obesity pill, its highest profile experimental drug, raises the odds that the drugmaker will ...

Pfizer just pulled the plug on its daily weight-loss pill, danuglipron, after a clinical trial flagged a potential ...

Pfizer Inc. has said it will discontinue development of its closely watched obesity pill, danuglipron, dealing a severe blow ...

When some of America’s most-influential CEOs were asked recently how much the stock market would need to fall before they ...

Signs of potential liver damage in a study participant led the company to abandon danuglipron, a drug it hoped would help it ...

China is prepared for “possible unexpected shocks,” Premier Li Qiang told a gathering of global executives in Beijing, where he urged them to “resist protectionism” and defend globalization.

BEIJING (AP) — China’s Premier Li Qiang said Sunday that Beijing and Washington should choose dialogue instead of confrontation, as the two countries are locked in rising friction over trade tariffs ...

Pfizer’s CEO Ian Read is to step down after eight years and will be replaced on 1st January by chief operating officer Albert Bourla. In contrast to Merck & Co. which has rescinded a company ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...